NO20085180L - Fremgangsmate og midler for behandling av inflammatorisk tarmsykdom - Google Patents

Fremgangsmate og midler for behandling av inflammatorisk tarmsykdom

Info

Publication number
NO20085180L
NO20085180L NO20085180A NO20085180A NO20085180L NO 20085180 L NO20085180 L NO 20085180L NO 20085180 A NO20085180 A NO 20085180A NO 20085180 A NO20085180 A NO 20085180A NO 20085180 L NO20085180 L NO 20085180L
Authority
NO
Norway
Prior art keywords
patient
inflammatory bowel
bowel disease
support agent
antibodies
Prior art date
Application number
NO20085180A
Other languages
English (en)
Norwegian (no)
Inventor
Magnus Thorn
Ola Winqvist
Original Assignee
Ibd Column Therapies Internat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ibd Column Therapies Internat filed Critical Ibd Column Therapies Internat
Publication of NO20085180L publication Critical patent/NO20085180L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20085180A 2006-05-12 2008-12-11 Fremgangsmate og midler for behandling av inflammatorisk tarmsykdom NO20085180L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0601075 2006-05-12
PCT/SE2007/000459 WO2007133147A1 (fr) 2006-05-12 2007-05-14 Procédé et moyens pour traiter les maladies inflammatoires chroniques de l'intestin

Publications (1)

Publication Number Publication Date
NO20085180L true NO20085180L (no) 2008-12-11

Family

ID=38694153

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085180A NO20085180L (no) 2006-05-12 2008-12-11 Fremgangsmate og midler for behandling av inflammatorisk tarmsykdom

Country Status (21)

Country Link
US (1) US8449489B2 (fr)
EP (1) EP2021025B1 (fr)
JP (1) JP5266207B2 (fr)
KR (1) KR20090007642A (fr)
CN (1) CN101443041A (fr)
AU (1) AU2007250552B2 (fr)
CA (1) CA2651883C (fr)
CY (1) CY1118286T1 (fr)
DK (1) DK2021025T3 (fr)
EA (1) EA016851B1 (fr)
ES (1) ES2603203T3 (fr)
HU (1) HUE032241T2 (fr)
IL (1) IL195001A0 (fr)
LT (1) LT2021025T (fr)
NO (1) NO20085180L (fr)
PL (1) PL2021025T3 (fr)
PT (1) PT2021025T (fr)
SG (1) SG171684A1 (fr)
SI (1) SI2021025T1 (fr)
WO (1) WO2007133147A1 (fr)
ZA (1) ZA200809429B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG165328A1 (en) 2005-08-31 2010-10-28 Ith Immune Therapy Holdings Ab Treatment of inflammatory bowel disease
JP5266207B2 (ja) 2006-05-12 2013-08-21 アイテーエイチ イミューン セラピー ホールディングス エービー 炎症性腸疾患を治療するための方法及び手段
US20110081649A1 (en) * 2007-08-02 2011-04-07 Iss Immune System Stimulation Ab Diagnosis, staging and monitoring of inflammatory bowel disease
CN102186880A (zh) * 2008-09-10 2011-09-14 Ith免疫治疗控股股份公司 炎症的治疗
US10099227B2 (en) 2009-08-25 2018-10-16 Nanoshell Company, Llc Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system
US11285494B2 (en) 2009-08-25 2022-03-29 Nanoshell Company, Llc Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system
WO2012099721A2 (fr) * 2011-01-18 2012-07-26 The Regents Of The University Of California Système immunitaire adaptatif en temps réel et procédé associé
US8979787B2 (en) * 2011-01-20 2015-03-17 Henry John Smith Treatment of pre-eclampsia using targeted apheresis
WO2012172339A2 (fr) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Traitement de l'arthrite inflammatoire
WO2012172343A2 (fr) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Traitement de l'angiocholite sclérosante primitive
WO2012172345A2 (fr) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Traitement d'états associés à l'allergie
US9726666B2 (en) 2011-06-13 2017-08-08 Tla Targeted Immunotherapies Ab Diagnosing and treating inflammatory diseases
ES2664836T3 (es) * 2011-06-13 2018-04-23 Tla Targeted Immunotherapies Ab Tratamiento de esclerosis múltiple
EP2718310B1 (fr) * 2011-06-13 2017-08-23 TLA Targeted Immunotherapies AB Traitement de troubles mentaux
DK2718312T3 (en) * 2011-06-13 2018-10-15 Tla Targeted Immunotherapies Ab TREATMENT OF CONDITIONS CONNECTED WITH SEPSIS
DK3228631T3 (da) * 2011-06-13 2020-09-28 Tla Targeted Immunotherapies Ab Behandling af respiratoriske tilstande
WO2012172337A2 (fr) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Traitement de maladie cardiovasculaire
WO2012172336A2 (fr) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Traitement de maladies inflammatoires de la peau
US10073097B2 (en) * 2012-11-28 2018-09-11 Charles C. Caldwell Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
EP3131559B1 (fr) * 2014-04-16 2019-02-13 Genovie AB Lymphocytes t régulateurs des cd8+ à utiliser dans le traitement de troubles inflammatoires du tractus gastro-intestinal humain
WO2015158855A1 (fr) 2014-04-16 2015-10-22 Genovie Ab Lymphocytes t régulateurs à utiliser dans le traitement de troubles inflammatoires du tractus gastro-intestinal humain
US12433985B2 (en) 2019-09-30 2025-10-07 Hemotune Ag Assembly for extracorporeal treatment of body fluids
WO2024122553A1 (fr) * 2022-12-05 2024-06-13 国立大学法人京都大学 Méthode de traitement de la rectocolite hémorragique ou de la cholangite sclérosante primitive
WO2024249568A1 (fr) 2023-05-30 2024-12-05 Paragon Therapeutics, Inc. Compositions d'anticorps anti-intégrine alpha4beta7 et procédés d'utilisation
CN121889424A (zh) 2023-08-14 2026-04-17 派拉冈医疗公司 α4β7整联蛋白结合蛋白及使用方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS639449A (ja) 1986-07-01 1988-01-16 テルモ株式会社 血液成分分離用器具
JPH0649653B2 (ja) 1988-06-29 1994-06-29 テルモ株式会社 白血球分離材、分離器および分離方法
JPH02167071A (ja) 1988-12-19 1990-06-27 Terumo Corp 非ヒト動物由来白血球系細胞の分離材、分離器および分離方法
JPH0374A (ja) 1988-12-31 1991-01-07 Tonen Corp 白血球吸着分離材
JPH04187206A (ja) 1990-11-19 1992-07-03 Toyobo Co Ltd 白血球分離装置及び白血球分離材料の製造方法
US5728306A (en) 1994-12-23 1998-03-17 Baxter International Inc. Leukodepletion filter and method for filtering leukocytes from freshly drawn blood
DE19538641C2 (de) * 1995-10-05 2000-09-21 Privates Inst Bioserv Gmbh Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung
JPH1057477A (ja) 1996-08-26 1998-03-03 Asahi Medical Co Ltd 白血球除去フィルター材および白血球除去フィルター装置
JP4197545B2 (ja) * 1997-12-01 2008-12-17 旭化成クラレメディカル株式会社 特異的細胞除去材料
EE200100123A (et) * 1998-08-31 2002-06-17 Biogen, Incorporated CD2 siduva aine kasutamine ja mäluefektor-T-lümfotsüütide populatsioon
GB0022748D0 (en) 2000-09-15 2000-11-01 Allied Therapeutics Ltd Reducing the content of cells in a biological sample
JP2003265596A (ja) 2002-03-12 2003-09-24 Asahi Kasei Corp 白血球選択吸着剤及びその評価選択方法
US6936222B2 (en) * 2002-09-13 2005-08-30 Kenneth L. Franco Methods, apparatuses, and applications for compliant membrane blood gas exchangers
US20060234210A1 (en) 2004-04-14 2006-10-19 Affinergy, Inc. Filtration device and method for removing selected materials from biological fluids
DE102005036505A1 (de) 2004-07-30 2006-06-01 Adexter Gmbh Vorrichtung und Verfahren zum Isolieren von Zellen, Biopartikeln und/oder Molekülen aus Flüssigkeiten mit dem Ziel einer Anwendung zur Behandlung von Krankheiten des Menschen
WO2006125201A2 (fr) 2005-05-19 2006-11-23 Centocor, Inc. Anticorps anti-muteines mcp-1 biotine-pegylees, compositions, procedes et utilisations correspondants
JP5266207B2 (ja) 2006-05-12 2013-08-21 アイテーエイチ イミューン セラピー ホールディングス エービー 炎症性腸疾患を治療するための方法及び手段
CN101522232B (zh) 2006-09-29 2012-03-21 东丽株式会社 细胞吸附柱

Also Published As

Publication number Publication date
LT2021025T (lt) 2017-01-25
AU2007250552A1 (en) 2007-11-22
EA016851B1 (ru) 2012-08-30
ZA200809429B (en) 2009-08-26
JP2009536944A (ja) 2009-10-22
EP2021025A1 (fr) 2009-02-11
IL195001A0 (en) 2011-08-01
CA2651883A1 (fr) 2007-11-22
US8449489B2 (en) 2013-05-28
EA200802086A1 (ru) 2009-06-30
ES2603203T3 (es) 2017-02-24
DK2021025T3 (en) 2016-12-12
SI2021025T1 (sl) 2017-02-28
SG171684A1 (en) 2011-06-29
PL2021025T3 (pl) 2017-04-28
CA2651883C (fr) 2017-05-30
US20090192434A1 (en) 2009-07-30
HUE032241T2 (en) 2017-09-28
JP5266207B2 (ja) 2013-08-21
KR20090007642A (ko) 2009-01-19
AU2007250552B2 (en) 2011-07-07
EP2021025A4 (fr) 2010-08-18
CN101443041A (zh) 2009-05-27
CY1118286T1 (el) 2017-06-28
EP2021025B1 (fr) 2016-08-17
WO2007133147A1 (fr) 2007-11-22
PT2021025T (pt) 2016-11-21

Similar Documents

Publication Publication Date Title
NO20085180L (no) Fremgangsmate og midler for behandling av inflammatorisk tarmsykdom
EA201000131A1 (ru) Диагностика, определение стадии и мониторинг воспалительного заболевания кишечника
Heinrich et al. Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells
WO2009121031A4 (fr) Procédé d'identification de nouveaux candidats thérapeutiques via l'analyse d'expression génique dans les maladies d'origine vasculaire
WO2006073682A3 (fr) Test diagnostique
AR107561A2 (es) Ensayo elisa para la detección de vegf
EP3708682A3 (fr) Utilisation de microvésicules dans le diagnostic et le pronostic de maladies et d'état de santé
DE602005024810D1 (de) Verfahren zum frühen nachweis einer nierenkrankheit und -verletzung
JP2007527287A5 (fr)
ATE517577T1 (de) Atementnahmevorrichtung
WO2003064994A3 (fr) Procedes pour recueillir un echantillon de l'haleine d'un sujet humain et pour analyser ledit echantillon
EP2209495A4 (fr) Taz/wwtr1 pour diagnostic et traitement de cancer
US20110159561A1 (en) Kit and method for the capture of tumor cells
WO2008093076A3 (fr) Analyses et thérapie
WO2006084299A8 (fr) Technique d'evaluation de la sensibilite allergique d'un individu
Remuzzi et al. Albumin concentration in the Bowman's capsule: multiphoton microscopy vs micropuncture technique
CN105177152A (zh) 检测hla-b*51等位基因的方法和引物
CN107058470B (zh) 一种通过联合miR-136和miR-4791预测急性高山病发病风险的诊断试剂盒
CN217390957U (zh) 小动物动态暴露吸入笑气实验系统
WO2006089219A3 (fr) Detection de neoepitope de maladie a l'aide de reseaux de proteines
ATE347696T1 (de) Verfahren zur diagnose von chronisch entzündlichen darmerkrankungen
ATE487692T1 (de) Verfahren und verbindungen zum nachweis von medizinischen erkrankungen
WO2000073338A8 (fr) Compositions et méthodes pour traiter, diagnostiquer et surveiller l'évolution du cancer du sein
Kato et al. Smad1 as a biomarker for diabetic nephropathy
Zou et al. Triterpenoid saponins from Cortex Albiziae

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application